Editorial Board Member - JCS
Suling Liu
ProfessorSchool of Life Sciences
University of Science & Technology
China
RESEARCH INTERESTS:
- Identifying different states of breast stem cells to develop the novel combination therapies targeting different breast cancer stem cells.
- Investigating the combination therapy of PARPi and 17-AAG to target cancer stem cells in Triple-negative breast cancers.
- Studying the effects of microRNAs on breast cancer stem cell self-renewal and differentiation, and develop some miRNA-based therapies with nanotechnology.
- Studying the tumor microenvironment in regulating breast cancer stem cells
Other Editorial Board Members - JCS
Peter Lobie
Principal Investigator
Cancer Science Institute of Singapore
National University of Singapore
Singapore
Cancer Science Institute of Singapore
National University of Singapore
Singapore
Kam C. Yeung
Associate Professor
Department of Biochemistry & Cancer Biology
University of Toledo College of Medicine
United States
Department of Biochemistry & Cancer Biology
University of Toledo College of Medicine
United States
Markus Müschen
Professor
Department of Laboratory Medicine
University of California, San Francisco
United States
Department of Laboratory Medicine
University of California, San Francisco
United States
XIAOYANG QI
Associate Director
Division of Hematology-Oncology
Department of Internal Medicine
University of Cincinnati
United States
Division of Hematology-Oncology
Department of Internal Medicine
University of Cincinnati
United States
Ken-ichi Mukaisho
Associate Professor
Department of Pathology
Division of Molecular Diagnostic Pathology
Shiga University of Medical Science
Japan
Department of Pathology
Division of Molecular Diagnostic Pathology
Shiga University of Medical Science
Japan
